Abstract
This 6-month observational, prospective, multicenter study assessed the influence of changes in seizure severity on quality of life in patients with refractory partial epilepsy. Patients ( N = 262) diagnosed with partial epilepsy and receiving two antiepileptic drugs as determined by usual clinical practice were enrolled in this study. The primary endpoint was the mean seizure severity score obtained from the Seizure Severity Questionnaire. Reductions in seizure severity were detected from baseline to months 3 and 6 ( P < 0.0001). Improvements compared with baseline were found for several secondary measures: Hamilton Anxiety and Depression scales ( P < 0.0001), most Medical Outcomes Study—Sleep subscales ( P < 0.05), and seven subscales of the Quality of Life in Epilepsy Inventory-31 (QOLIE-31; P < 0.0005). Seizure severity correlated directly with anxiety ( P < 0.0001) and inversely with QOLIE-31 measures ( P < 0.0001). In conclusion, reducing seizure severity with appropriate medication may lead to improvement in the overall quality of life of patients with refractory partial epilepsy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
